Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

azimilide dihydrochloride

Known as: 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-2,4-imidazolidinedione dihydrochloride, 2,4-Imidazolidinedione, 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-, dihydrochloride, Azimilide Hydrochloride 
National Institutes of Health

Related topics

Related topics

2 relations
NE 10064

Broader (1)

azimilide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.
OBJECTIVES The purpose of this study was to assess the incidence, temporal characteristics, and risk factors associated with… Expand
  • figure 1
  • table 4
  • table 2
2006
2006
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
Azimilide hydrochloride (azimilide), an investigational antiarrhythmic drug, has shown variable efficacy in preventing atrial… Expand
2006
2006
Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
BACKGROUND Azimilide dihydrochloride (azimilide) is an investigational antiarrhythmic drug that has been tested in patients with… Expand
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the… Expand
Highly Cited
2004
Highly Cited
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Highly Cited
2004
Highly Cited
2004
The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
OBJECTIVES The purpose of this study was to assess the effect of oral azimilide dihydrochloride (AZ) 100 mg versus placebo on the… Expand
Highly Cited
2004
Highly Cited
2004
Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
OBJECTIVES This study evaluated the effects of azimilide dihydrochloride (AZ) on anti-tachycardia pacing (ATP) and shock… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Review
1998
Review
1998
Azimilide dihydrochloride, a novel antiarrhythmic agent.
Azimilide, a novel class III antiarrhythmic agent, blocks both the slowly activating (IKs) and rapidly activating (IKr… Expand
1996
1996
Effects of Azimilide Dihydrochloride on Circus Movement Atrial Flutter in the Canine Sterile Pericarditis Model
Azimilide and Atrial Flutter. Introduction: The effects of a Class III agent, azimilide di‐hydrochloride, on atrial flutter… Expand
1996
1996
Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
The class III antiarrhythmics azimilide dihydrochloride and dl-sotalol were evaluated for ability to suppress induction of… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE